AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 1-25/51
LAPAROSCOPIC CHOLECYSTECTOMY AS A TRUE OUTPATIENT PROCEDURE - INITIALEXPERIENCE IN 100 CONSECUTIVE PATIENTS
Authors: LILLEMOE KD HARDACRE JM TALAMINI MA YEO CJ SNYDER DS PARKER SD
Citation: Kd. Lillemoe et al., LAPAROSCOPIC CHOLECYSTECTOMY AS A TRUE OUTPATIENT PROCEDURE - INITIALEXPERIENCE IN 100 CONSECUTIVE PATIENTS, Gastroenterology, 114(4), 1998, pp. 141-141
REMIFENTANIL PROVIDES SUPERIOR HEMODYNAMICS AND FASTER TIMES TO DISCHARGE THAN A FENTANYL BASED ANESTHETIC IN HIGH-RISK OUTPATIENT SURGERY
Authors: MACKEY JJ PARKER SD NASS CM MALHORTA VT SNYDER DS ZUCKERMAN RL FLEISHER LA
Citation: Jj. Mackey et al., REMIFENTANIL PROVIDES SUPERIOR HEMODYNAMICS AND FASTER TIMES TO DISCHARGE THAN A FENTANYL BASED ANESTHETIC IN HIGH-RISK OUTPATIENT SURGERY, Anesthesiology, 89(3A), 1998, pp. 32-32
ANALYSIS OF A MONOPHOSPHORYL LIPID-A IMMUNOSTIMULANT PREPARATION FROMSALMONELLA-MINNESOTA R595 BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
Authors: HAGEN SR THOMPSON JD SNYDER DS MYERS KR
Citation: Sr. Hagen et al., ANALYSIS OF A MONOPHOSPHORYL LIPID-A IMMUNOSTIMULANT PREPARATION FROMSALMONELLA-MINNESOTA R595 BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography, 767(1-2), 1997, pp. 53-61
ALLOGENEIC BONE-MARROW TRANSPLANT IN PEDIATRIC-PATIENTS WITH HIGH-RISK HEMATOPOIETIC MALIGNANCIES EARLY IN THE COURSE OF THEIR DISEASE
Authors: AMYLON MD CO JPT SNYDER DS DONALDSON SS BLUME KG FORMAN SJ
Citation: Md. Amylon et al., ALLOGENEIC BONE-MARROW TRANSPLANT IN PEDIATRIC-PATIENTS WITH HIGH-RISK HEMATOPOIETIC MALIGNANCIES EARLY IN THE COURSE OF THEIR DISEASE, Journal of pediatric hematology/oncology, 19(1), 1997, pp. 54-61
FRONTOTEMPORAL DEMENTIA AND PARKINSONISM LINKED TO CHROMOSOME-17 - A CONSENSUS CONFERENCE
Authors: FOSTER NL WILHELMSEN K SIMA AAF JONES MZ DAMATO CJ GILMAN S SPILLANTINI MG LYNCH T MAYEUX RP GASKELL PC HULETTE CM PERICAKVANCE MA WELSHBOHMER KA DICKSON DW HEUTINK P KROS J VANSWIETEN JC ARWERT F GHETTI MB MURRELL J LANNFELT L HUTTON M JONES M PHELPS CH SNYDER DS OLIVER E BALL MJ CUMMINGS JL MILLER BL KATZMAN R REED L SCHELPER RL LANDSKA DJ BRUN A FINK JK KUHL DE KNOPMAN DS WSZOLEK Z MILLER CA BIRD TD LENDON C ELECHI C
Citation: Nl. Foster et al., FRONTOTEMPORAL DEMENTIA AND PARKINSONISM LINKED TO CHROMOSOME-17 - A CONSENSUS CONFERENCE, Annals of neurology, 41(6), 1997, pp. 706-715
SAFETY OF DIRECT LARYNGOSCOPY AS AN OUTPATIENT PROCEDURE
Authors: ARMSTRONG M MARK LJ SNYDER DS PARKER SD
Citation: M. Armstrong et al., SAFETY OF DIRECT LARYNGOSCOPY AS AN OUTPATIENT PROCEDURE, The Laryngoscope, 107(8), 1997, pp. 1060-1065
ALLOGENEIC (ALLO) AND MATCHED UNRELATED DONOR (MUD) BONE-MARROW TRANSPLANTATION (BMT) IN 46 PATIENTS GREATER-THAN 50 YEARS OF AGE
Authors: KASHYAP A PARKER P NADEMANEE A FUNG H MOLINA A BHATIA R KRISHNAN A ODONNELL MR PLANAS I SNYDER DS SPIELBERGER R STEIN A LEE J FORMAN SJ
Citation: A. Kashyap et al., ALLOGENEIC (ALLO) AND MATCHED UNRELATED DONOR (MUD) BONE-MARROW TRANSPLANTATION (BMT) IN 46 PATIENTS GREATER-THAN 50 YEARS OF AGE, Blood, 90(10), 1997, pp. 468-468
HIGH-DOSE THERAPY AND AUTOLOGOUS STEM TRANSPLANTATION (ASCT) AS CONSOLIDATION THERAPY DURING FIRST COMPLETE REMISSION (CR) OR PARTIAL REMISSION (PR) IN PATIENTS WITH UNFAVORABLE PROGNOSIS AND ADVANCED-STAGE HODGKINS-DISEASE (HD)
Authors: NADEMANEE A MOLINA A STEIN A PLANAS I FUNG H DAGIS A ODONNELL MR SNYDER DS PARKER P SPIELBERGER R KASHYAP A BHATIA R KRISHNAN A SNIECINSKI K VORA N FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE THERAPY AND AUTOLOGOUS STEM TRANSPLANTATION (ASCT) AS CONSOLIDATION THERAPY DURING FIRST COMPLETE REMISSION (CR) OR PARTIAL REMISSION (PR) IN PATIENTS WITH UNFAVORABLE PROGNOSIS AND ADVANCED-STAGE HODGKINS-DISEASE (HD), Blood, 90(10), 1997, pp. 495-495
INHIBITION OF BCR-ABL ONCOGENE EXPRESSION BY NOVEL DEOXYRIBOZYMES (DNA-ZYMES)
Authors: SNYDER DS WU Y MCMAHON R YU L FORMAN SJ
Citation: Ds. Snyder et al., INHIBITION OF BCR-ABL ONCOGENE EXPRESSION BY NOVEL DEOXYRIBOZYMES (DNA-ZYMES), Blood, 90(10), 1997, pp. 790-790
ALLOGENEIC MARROW TRANSPLANTATION - A CURATIVE OPTION FOR TREATMENT RELATED MYELODYSPLASIA (MDS)
Authors: ODONNELL M STEIN A SNYDER DS NADEMANEE A PARKER PM SMITH EP MOLINA A KASHYAP A MARGOLIN K SOMLO G FORMAN SJ
Citation: M. Odonnell et al., ALLOGENEIC MARROW TRANSPLANTATION - A CURATIVE OPTION FOR TREATMENT RELATED MYELODYSPLASIA (MDS), Blood, 90(10), 1997, pp. 1008-1008
RESULTS OF HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION DURING REMISSION IN POOR-RISK INTERMEDIATE-GRADE AND HIGH-GRADE LYMPHOMA - INTERNATIONAL INDEX HIGH AND HIGH-INTERMEDIATE RISK GROUP
Authors: NADEMANEE A MOLINA A ODONNELL MR DAGIS A SNYDER DS PARKER P STEIN A SMITH E PLANAS I KASHYAP A SPIELBERGER R FUNG H WONG KK SOMLO G MARGOLIN K CHOW W SNIECINSKI I VORA N BLUME KG NILAND J FORMAN SJ
Citation: A. Nademanee et al., RESULTS OF HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION DURING REMISSION IN POOR-RISK INTERMEDIATE-GRADE AND HIGH-GRADE LYMPHOMA - INTERNATIONAL INDEX HIGH AND HIGH-INTERMEDIATE RISK GROUP, Blood, 90(10), 1997, pp. 3844-3852
IN-VIVO PURGING WITH HIGH-DOSE CYTARABINE FOLLOWED BY HIGH-DOSE CHEMORADIOTHERAPY AND REINFUSION OF UNPURGED BONE-MARROW FOR ADULT ACUTE MYELOGENOUS LEUKEMIA IN FIRST COMPLETE REMISSION
Authors: STEIN AS ODONNELL MR CHAI A SCHMIDT GM NADEMANEE A PARKER PM SMITH EP SNYDER DS MOLINA A STEPAN DE SPIELBERGER R SOMLO G MARGOLIN KA VORA N LIPSETT J LEE J NILAND J FORMAN SJ
Citation: As. Stein et al., IN-VIVO PURGING WITH HIGH-DOSE CYTARABINE FOLLOWED BY HIGH-DOSE CHEMORADIOTHERAPY AND REINFUSION OF UNPURGED BONE-MARROW FOR ADULT ACUTE MYELOGENOUS LEUKEMIA IN FIRST COMPLETE REMISSION, Journal of clinical oncology, 14(8), 1996, pp. 2206-2216
POLYMYOSITIS AS A MANIFESTATION OF CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: PARKER P CHAO NJ BENEZRA J SLATKIN N OPENSHAW H NILAND JC LINKER CA GREFFE BS KASHYAP A MOLINA A NADEMANEE A ODONNELL MR PLANAS I SHEIBANI K SMITH EP SNYDER DS SPIELBERGER R STEIN AS STEPAN DE BLUME KG FORMAN SJ
Citation: P. Parker et al., POLYMYOSITIS AS A MANIFESTATION OF CHRONIC GRAFT-VERSUS-HOST DISEASE, Medicine, 75(5), 1996, pp. 279-285
IMPROVED CR RATE USING HIGH-DOSE MELPHALAN (HDM) PRE G-CSF-PRIMED DONOR LEUKOCYTE INFUSION (DLI) FOR 2ND ALLOGENEIC BMT - ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PROPHYLAXIS IS NECESSARY FOR PATIENTS AT RISK FOR HYPERACUTE GVHD
Authors: PARKER PM KASHYAP A SPIELBERGER R SNIECZINSKI I CHOW W FUNG H MARGOLIN K MOLINA A NADEMANEE A ODONNELL M PLANAS I SMITH E SNYDER DS SOMLO G STEIN A FORMAN SJ
Citation: Pm. Parker et al., IMPROVED CR RATE USING HIGH-DOSE MELPHALAN (HDM) PRE G-CSF-PRIMED DONOR LEUKOCYTE INFUSION (DLI) FOR 2ND ALLOGENEIC BMT - ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PROPHYLAXIS IS NECESSARY FOR PATIENTS AT RISK FOR HYPERACUTE GVHD, Blood, 88(10), 1996, pp. 3805-3805
HIGH-DOSE CHEMO RADIOTHERAPY (HDT) AND G-CSF PRIMED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN FOLLICULAR LOW-GRADE (FLGL) AND TRANSFORMED (TL) LYMPHOMA/
Authors: MOLINA A NADEMANEE A ODONNELL MR SNYDER DS STEIN AS PARKER PM SMITH EP LEE J PLANAS I KASHYAP A SPIELBERGER RT MARGOLIN K SOMLO G KAPOOR N CHOW W VORA N SNIECINSKI I NILAND J FORMAN SJ
Citation: A. Molina et al., HIGH-DOSE CHEMO RADIOTHERAPY (HDT) AND G-CSF PRIMED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN FOLLICULAR LOW-GRADE (FLGL) AND TRANSFORMED (TL) LYMPHOMA/, Blood, 88(10), 1996, pp. 472-472
RIBOZYME-MEDIATED INHIBITION OF A PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINE EXPRESSING THE P190 BCR-ABL ONCOGENE
Authors: SNYDER DS WU Y MCMAHON R YU L FORMAN SJ
Citation: Ds. Snyder et al., RIBOZYME-MEDIATED INHIBITION OF A PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINE EXPRESSING THE P190 BCR-ABL ONCOGENE, Blood, 88(10), 1996, pp. 821-821
DO CYTOGENETICS PREDICT OUTCOME OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 1ST REMISSION (CR)
Authors: STEIN AS ODONNELL MR SLOVAK M LEE J KASHYAP A MOLINA A NADEMANEE A PARKER P PLANAS I SNYDER DS SPIELBERGER R SOMLO G MARGOLIN K NILAND J FORMAN SJ
Citation: As. Stein et al., DO CYTOGENETICS PREDICT OUTCOME OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 1ST REMISSION (CR), Blood, 88(10), 1996, pp. 1928-1928
ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS (PTS) WITH INCURABLE LOW-GRADE LYMPHOPROLIFERATIVE DISORDERS (LGLPD)
Authors: MOLINA A PARKER P STEIN AS SPIELBERGER R NADEMANEE A SNYDER DS ODONNELL MR SMITH EP MARGOLIN K DAGIS A PLANAS I KASHYAP A SOMLO G KAPOOR N VORA N NILAND J FORMAN SJ
Citation: A. Molina et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS (PTS) WITH INCURABLE LOW-GRADE LYMPHOPROLIFERATIVE DISORDERS (LGLPD), Blood, 88(10), 1996, pp. 2465-2465
HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION (ABMT) AS CONSOLIDATION THERAPY DURING FIRST CR PR IN PATIENTS WITH POOR-RISK INTERMEDIATE-AND HIGH-GRADE LYMPHOMA/
Authors: NADEMANEE A MOLINA A ODONNELL M SNYDER DS STEIN A PARKER P SMITH E KASHYAP A PLANAS I SPIELBERGER R FUNG H SOMLO G MARGOLIN K CHOW W VORA N DAGIS A NILAND J BLUME KG FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION (ABMT) AS CONSOLIDATION THERAPY DURING FIRST CR PR IN PATIENTS WITH POOR-RISK INTERMEDIATE-AND HIGH-GRADE LYMPHOMA/, Blood, 88(10), 1996, pp. 2725-2725
STRUCTURAL AND BIOLOGICAL CHARACTERIZATION OF UNMODIFIED RE LIPOPOLYSACCHARIDE FRACTIONS-ISOLATED BY NORMAL-PHASE CHROMATOGRAPHY
Authors: SNYDER DS WHITAKER KL MYERS KR
Citation: Ds. Snyder et al., STRUCTURAL AND BIOLOGICAL CHARACTERIZATION OF UNMODIFIED RE LIPOPOLYSACCHARIDE FRACTIONS-ISOLATED BY NORMAL-PHASE CHROMATOGRAPHY, The FASEB journal, 9(3), 1995, pp. 520-520
BUSULFAN CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA/
Authors: ODONNELL MR LONG GD PARKER PM NILAND J NADEMANEE A AMYLON M CHAO N NEGRIN RS SCHMIDT GM SLOVAK ML SMITH EP SNYDER DS STEIN AS TRAWEEK T BLUME KG FORMAN SJ
Citation: Mr. Odonnell et al., BUSULFAN CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA/, Journal of clinical oncology, 13(12), 1995, pp. 2973-2979
THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: PARKER PM CHAO N NADEMANEE A ODONNELL MR SCHMIDT GM SNYDER DS STEIN AS SMITH EP MOLINA A STEPAN DE KASHYAP A PLANAS I SPIELBERGER R SOMLO G MARGOLIN K ZWINGENBERGER K WILSMAN K NEGRIN RS LONG GD NILAND JC BLUME KG FORMAN SJ
Citation: Pm. Parker et al., THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 86(9), 1995, pp. 3604-3609
THE OUTCOME OF MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION INPATIENTS WITH HEMATOLOGIC MALIGNANCIES USING MOLECULAR TYPING FOR DONOR SELECTION AND GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS REGIMEN OF CYCLOSPORINE, METHOTREXATE, AND PREDNISONE
Authors: NADEMANEE A SCHMIDT GM PARKER P DAGIS AC STEIN A SNYDER DS ODONNELL M SMITH EP STEPAN DE MOLINA A WONG KK MARGOLIN K SOMLO G LITTRELL B WOO D SNIECINSKI I NILAND JC FORMAN SJ
Citation: A. Nademanee et al., THE OUTCOME OF MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION INPATIENTS WITH HEMATOLOGIC MALIGNANCIES USING MOLECULAR TYPING FOR DONOR SELECTION AND GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS REGIMEN OF CYCLOSPORINE, METHOTREXATE, AND PREDNISONE, Blood, 86(3), 1995, pp. 1228-1234
INHIBITION OF GROWTH OF A PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINE BY ANTISENSE OLIGONUCLEOTIDES SPECIFIC FOR THE P190 BCR-ABL ONCOGENE
Authors: SNYDER DS WU Y MCMAHON R FORMAN SJ
Citation: Ds. Snyder et al., INHIBITION OF GROWTH OF A PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINE BY ANTISENSE OLIGONUCLEOTIDES SPECIFIC FOR THE P190 BCR-ABL ONCOGENE, Blood, 86(10), 1995, pp. 2956-2956
HIGH-DOSE CHEMOTHERAPY WITH OR WITHOUT TOTAL-BODY IRRADIATION FOLLOWED BY AUTOLOGOUS BONE-MARROW AND OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED AND REFRACTORY HODGKINS-DISEASE - RESULTS IN 85 PATIENTS WITH ANALYSIS OF PROGNOSTIC FACTORS/
Authors: NADEMANEE A ODONNELL MR SNYDER DS SCHMIDT GM PARKER PM STEIN AS SMITH EP MOLINA A STEPAN DE SOMLO G MARGOLIN KA SNIECINSKI I DAGIS AC NILAND J PEZNER R FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE CHEMOTHERAPY WITH OR WITHOUT TOTAL-BODY IRRADIATION FOLLOWED BY AUTOLOGOUS BONE-MARROW AND OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED AND REFRACTORY HODGKINS-DISEASE - RESULTS IN 85 PATIENTS WITH ANALYSIS OF PROGNOSTIC FACTORS/, Blood, 85(5), 1995, pp. 1381-1390
Risultati: 1-25 | 26-50 | 51-51